SFL's Managing Director to Moderate Panel Discussion at EuroMedTech event in Grenoble, France
Shayesteh Fürst-Ladani, Managing Director of SFL to moderate panel discussion at upcoming EuroMedTech event.
- (1888PressRelease) May 09, 2012 - SFL is pleased to announce that Shayesteh Fürst-Ladani, Managing Director of the company, will be moderating a panel discussion entitled "Shifting sands: Regulatory developments in uncertain times" to be held at the fourth annual EuroMedtech international medtech partnering conference.
"The fine line that European regulatory agencies must tread between patient safety and fostering innovation is under greater scrutiny than ever before," commented Shayesteh. "In the panel discussion we will be exploring the unique features of different regulatory systems and the perceived hurdles for companies. In addition, we will examine upcoming changes to the European framework, especially with respect to their impact on SMEs' interactions with regulatory bodies."
EuroMedtech, which will be taking place from May 31-June 1, 2012 in Grenoble, France, is an event that provides collaboration opportunities to medtech decision makers and investors. It caters to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories, through to diagnostics, imaging and eHealth, and also to those involved in platform technologies such as biomaterials and augmented medicine.
Shayesteh is the Managing Director and founder of SFL Regulatory Affairs & Scientific Communication Ltd. She leads the team and provides global strategic support for the development of healthcare products. Shayesteh has a comprehensive knowledge base and experience in formulating global regulatory strategy for drugs, orphan drugs, drug & device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products.
About SFL Regulatory Affairs & Scientific Communication Ltd
SFL provides a holistic approach to lifecycle management of healthcare products. The company's team of professionals have experience in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications. We support our clients by offering personalized and comprehensive services. When combined, these services provide an integral oversight package for products from the bench to the marketplace at one consultancy.